Results 41 to 50 of about 9,448,988 (355)

Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase [PDF]

open access: yes, 2015
Background Statins are first-line therapy for cardiovascular disease prevention, but their systemic effects across lipoprotein subclasses, fatty acids, and circulating metabolites remain incompletely characterized.
Ala-Korpela, M   +25 more
core   +2 more sources

Modulator Therapy for Cystic Fibrosis: An Exploration of Current Research [PDF]

open access: yes, 2020
Developing a drug therapy that addresses the root cause of cystic fibrosis (CF) by increasing CFTR protein levels has long been a research challenge. After genetic therapy failed because a suitable delivery system could not be found, researchers began ...
Rombocos, Jessalyn
core   +1 more source

Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy [PDF]

open access: yes, 2014
Hepatitis C virus (HCV) infection represents an important public health problem worldwide. Reduction of HCV morbidity and mortality is a current challenge owned to several viral and host factors.
Carpio Pedroza, Juan Carlos   +10 more
core   +1 more source

Extracellular vesicles: the next generation in gene therapy delivery.

open access: yesMolecular Therapy, 2023
Extracellular vesicles (EVs) are esteemed as a promising delivery vehicle for various genetic therapeutics. They are relatively inert, non-immunogenic, biodegradable, and biocompatible.
Riccardo Cecchin   +3 more
semanticscholar   +1 more source

Targeting Oncogenic BRAF: Past, Present, and Future. [PDF]

open access: yes, 2019
Identifying recurrent somatic genetic alterations of, and dependency on, the kinase BRAF has enabled a "precision medicine" paradigm to diagnose and treat BRAF-driven tumors.
Bivona, Trever G   +2 more
core   +1 more source

Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

open access: yesFrontiers in Genetics, 2019
The field of gene therapy is striving more than ever to define a path to the clinic and the market. Twenty gene therapy products have already been approved and over two thousand human gene therapy clinical trials have been reported worldwide.
Alireza Shahryari   +8 more
semanticscholar   +1 more source

Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics. [PDF]

open access: yes, 2020
Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for regenerative therapy, disease modeling, and drug discovery.
Chandy, Mark   +2 more
core  

The molecular basis for ethnic variation and histological subtype differences in prostate cancer. [PDF]

open access: yes, 2013
Prostate cancer is a common malignancy among men in Western countries. Recently the morbidity and mortality of prostate cancer increase dramatically in several oriental countries including China.
Goldstein, Andrew S   +2 more
core   +1 more source

Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

open access: yesCirculation, 2019
Supplemental Digital Content is available in the text.
P. García-Pavía   +51 more
semanticscholar   +1 more source

Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders

open access: yesNature Communications, 2019
Fifty percent of inner ear disorders are caused by genetic mutations. To develop treatments for genetic inner ear disorders, we designed gene replacement therapies using synthetic adeno-associated viral vectors to deliver the coding sequence for ...
Carl Nist-Lund   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy